juan scaliter

Technology

FDA Approves Moderna's First mRNA Flu Vaccine mFLUSIVA

The U.S. Food and Drug Administration has approved Moderna's mFLUSIVA, making it the first messenger RNA flu vaccine for adults aged 50 and older.